In this first-ever proof-of-concept study for the therapeutic potential of human iPSC-derived cells in a pulmonary disease,  Christine Happle and colleagues use Chipcytometry to analyse the successful transplantation of these cells in a humanized mouse model of hereditary pulmonary alveolar proteinosis (herPAP).

https://www.ncbi.nlm.nih.gov/pubmed/29652170

Contact Us

Please tell us how we can help you.

Not readable? Change text. captcha txt

Start typing and press Enter to search